Nightingale Health
2,98
EUR
-0,67 %
Corporate customer
HEALTH
First North Finland
Medical Equipment & Services
Health Care
4.534 følger denne virksomhed
-0,67%
+3,47%
+7,19%
+2,41%
+41,9%
+159,13%
-9,48%
-
-42,14%
Nightingale Health operates in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes platforms and services in blood tests that are used for disease prevention purposes. In addition to the main business, service and associated ancillary services are also offered. The business is run globally with the largest presence in Europe.
Læs mereMarkedsværdi
181,57 mio. EUR
Aktieomsætning
132,24 t EUR
P/E (adj.) (25e)
-10,71
EV/EBIT (adj.) (25e)
-7,21
P/B (25e)
2,63
EV/S (25e)
19,72
Udbytteafkast, % (25e)
-
Coverage
Head of Nordic ER Development, Analyst
Revenue and EBIT-%
Omsætning
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Udbytte %
Finanskalender
6.3
2025
Delårsrapport Q2'25
Risiko
Business risk
Valuation risk
Lav
Høj
ViserAlle indholdstyper
Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region
Nightingale Health published new disease risk assessments
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools